Managing Medicines Safely Human Factors Vivienne van Someren & Chloe Benn.

Slides:



Advertisements
Similar presentations
Medication Management
Advertisements

The Thrombosis Committee: an Instrument for Governance & Change
The Patient Safety Challenge in the UK Dr Kevin Cleary Medical Director National Patient Safety Agency.
National Adult Clozapine Titration Chart
CQC registration for providers of Primary Dental Services Medicines Management Caroline Crouch NHS Dorset.
Disease State Management The Pharmacist’s Role
Medication Error Safe(er) Prescribing Gentamicin in Neonates Anil Tuladhar C Harikumar Debbie Bryan.
What’s different about paediatric prescribing.  Vary in their developmental stages ◦ Pre-term, neonates, infants, children, adolescents  Dynamic anatomy.
SBAR Situation Background Assessment Recommendation
Protecting patients- now and in the future Linda Matthew Senior Pharmacist National Patient Safety Agency.
Wendy Bagnall Medicines Management Technician Walsall tPCT.
RENI PRIMA GUSTY, SK.p,M.Kes
Emergency Oxygen Professor Thida Win 10/03/2015SCN Emergency Oxygen Event.
Quality Improvement Prepeared By Dr: Manal Moussa.
Error Prone Abbreviations
Clinical Training: Medication Reconciliation
Clinical pharmacy Dr. Mohammed Al-Rekabi Lecture One First Semester.
Standard 4: Medication Safety Advice Centre Network Meeting Margaret Duguid Pharmaceutical Advisor February 2013.
Unlicensed Medicines in Paediatrics Is there a problem ? Scottish Neonatal and Paediatric Pharmacist Group National Paediatric Pre- Registration Pharmacist.
by Joint Commission International (JCI)
Testing People Scientifically.  Clinical trials are research studies in which people help doctors and researchers find ways to improve health care. Each.
 Definitions  Goals of automation in pharmacy  Advantages/disadvantages of automation  Application of automation to the medication use process  Clinical.
Dr. Rosaline Kinuthia Clinical pharmacist KNH. Optimize patients outcomes through the judicious, safe, efficacious, appropriate and cost effective use.
Reducing Medication Errors findings of the National Clinical Governance Protected Time Project Paul MooreClinical Governance Manager.
Being Part of a Core Group Jacqui Westbury – CP Chair/IRO Team Manager Kate Lawson - Safeguarding Nurse Specialist.
Prescribing Errors in General Practice The PRACtICe Study (2012) GMC Investigating Prevalence and Causes.
Preventing Surgical Complications Prevent Harm from High Alert Medication- Anticoagulants in Primary Care Insert Date here Presenter:
‘Safer use of intravenous gentamicin for neonates’ how-to guide.
Clinical Pharmacy Part 2
Standard 4: Medication Safety Advice Centre Network Meeting Margaret Duguid Pharmaceutical Advisor February 2013.
CLT Conference th July 2015 Medication Management Training for Mental Health Student Nurses By Candi, Richard & Paul Edge Hill University.
SPSP Medicines Paediatric Networking Event Prepared by: David Maxwell.
Is the 7 day service the future of pharmacy in acute medicine? David Young.
BNF for children and formulations Ian Costello British National Formulary.
Promoting Drug and Therapeutics Committees in the Developing World
Principles of Medication Administration and Medication Safety Chapter 7 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of.
Emtenan AlHarbi,Mcs Clinical pharmacist
Around one million people in the UK \on insulin injections to control levels of glucose Statistics show there have been 3,931 serious incidents involving.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
Standard 10: Preventing Falls and Harm from Falls Accrediting Agencies Surveyor Workshop, 13 August 2012.
Introduction.
Preventing Errors in Medicine
Amy Wilson-Stronks 1, Lance Patak 2, John Costello 3 1 The Joint Commission, Oakbrook Terrace, IL 2 University of Michigan Medical Center, 3 Children’s.
 Promote health, prevent illness/injury  Broad knowledge base needed to meet patient needs in different health care settings.
Agenda BupaPrivate and Confidential Implementing a training and accreditation scheme for TTA pre-pack dispensing R Betmouni, N Gillani Pharmacy Department,
How the Clinical Effectiveness Team can help you to audit your Prescribing Practice Jude Scott Clinical Governance & Risk Management Unit Clinical Effectiveness.
UNIVERSITY OF SAN FRANCISCO N653 INTERNSHIP: CLINICAL NURSE LEADER ANGELA HUANG Medication Transcription Error Prevention.
Implementing NICE guidance on autism – developing a local autism team January 2014 Autism: the management and support of children and young people on the.
Workshop to introduce local selection of monographs from national midwifery formulary.
GB.DRO f, date of preparation: January 2010 Dartford and Gravesham NHS Trust Pharmacy Services in Hospital.
 Pharmaceutical Care is a patient-centered, outcomes oriented pharmacy practice that requires the pharmacist to work in concert with the patient and.
Medicines adherence Implementing NICE guidance 2009 NICE clinical guideline 76.
Strategies and Tools to Enhance Performance and Patient Safety Adoption in Action AHRQ funded project UNCHCS/RTI partnership READY Training OR 6.
Safety in Medicines: Raising the profile with the Royal Pharmaceutical Society Liz Rawlins Communications Officer 9 May 2011.
European Community Pharmacy Blueprint A perspective from general practice Professor Tony Avery.
At a Glance: Omitted Doses 1. Before signing the drug chart, ask… Why is the patient unable to take the dose? Is this medicine a time critical medicine?
An Audit to Determine if Prescribers are Reviewing Antimicrobial Prescriptions Hours After Initiation. Natalie Holman, Emma Cramp, Joy Baruah Hinchingbrooke.
Critical Care Services Pharmacist Royal Manchester Children’s Hospital
Risk Communication in Medicines
Methotrexate in Psoriasis Shared Care Guidelines
Dynamic Discharging in Medicine
Tools & Strategies Summary
Medication Safety Dr. Kanar Hidayat
The Nursing Process and Pharmacology Jeanelle F. Jimenez RN, BSN, CCRN
Reducing Medication Errors with ePMA: 7 Years Experience
Outline Why Focus on PN Safety? PN Safety Gap Analysis Survey Results
Chemotherapy Services in England: Ensuring quality and safety
Situation Monitoring Know the plan, share the plan, review the risks.
Medication Safety Dr. Kanar Hidayat
Hospital pharmacy.
Presentation transcript:

Managing Medicines Safely Human Factors Vivienne van Someren & Chloe Benn

Acknowledgements The concepts and graphics used in this presentation are based on those developed for the Advanced Resuscitation of the Newborn Infant Course of the Resuscitation Council (UK) by Dr John Madar and others. The copyright belongs to the Resuscitation Council. I have adapted their material and used examples relevant to Medicines Safety Vivienne van Someren

Aims To be aware of the human factors which may influence the effective management of medicines for children.

Effective Resource Management SYSTEMS PROCESS PROCEDURES HUMAN FACTORS

Systems Planning Prevents Problems

Systems BNF C Licensing – MHRA Research Governance

Processes Systematic approach E prescribing Drug chart design Procurement Specialist training? Dose banding

Procedures Appropriate skills, well rehearsed Right equipment, right place, right time Contingencies for failure

Procedures NPSA gentamicin bundle Medicines reconciliation Do not disturb medicines rounds

Well rehearsed procedures and situations

Human Factors Situation awareness Decision making Team working & leadership Task management

Situation Awareness Global Overview Clear Vision - Systems Check Goals - Direction of travel Time - Progress Resources - Help Deviation - Fixation errors

Decision making Leadership role Clear communication What Who When Why

Errors Slips and Trips Cognitive errors ? Examples from your experience

Cognitive Errors Ignorance Fixation Assumption Arrogance –(confidence/competence mismatch) Misinterpretation Miscomprehension

Your experience? Cognitive errors

Cognitive Errors Ignorance Fixation Assumption Arrogance –(confidence/competence mismatch) Misinterpretation Miscomprehension

Team Working For the collective good Clear goals / strategies Work together Accept leadership / roles Suspend hierarchies Respect others Actively contribute Discipline Rehearsal

Task Management Delegation Collaboration Coordination

Communication Effective communication is vital at all stages Common language Inclusive - within team, between teams Dynamic Structured (SBAR) ‘closed loop’ Moderated (through team leader) Polite

SBAR A paediatrician has written a newborn baby up for abacavir, 3TC and kaletra. The BNF C says these drugs are not licensed in the newborn period and does not give any doses. You need to ring the paediatrician to discuss

SBAR Situation Who you are and what the call is about

SBAR Situation I am the pharmacist for the maternity unit and I am phoning to discuss the prescription for antiretrovirals for Baby A

SBAR Situation I am the pharmacist for the maternity unit and I am phoning to discuss the prescription for antiretrovirals for Baby A Background

SBAR Situation I am the pharmacist for the maternity unit and I am phoning to discuss the prescription for antiretrovirals for Baby A Background I see the mother is HIV positive and on treatment and that you have prescribed ABC, 3TC and Kaletra for the baby.

SBAR Situation I am the pharmacist for the maternity unit and I am phoning to discuss the prescription for antiretrovirals for Baby A Background I see the mother is HIV positive and on treatment and that you have prescribed ABC, 3TC and Kaletra for the baby. Assessment

SBAR Situation I am the pharmacist for the maternity unit and I am phoning to discuss the prescription for antiretrovirals for Baby A Background I see the mother is HIV positive and on treatment and that you have prescribed ABC, 3TC and Kaletra for the baby. Assessment I am worried because we usually use zidovudine, because these drugs are not licensed for use in the newborn and because the doses are not given in the BNF C

SBAR Situation I am the pharmacist for the maternity unit and I am phoning to discuss the prescription for antiretrovirals for Baby A Background I see the mother is HIV positive and on treatment and that you have prescribed ABC, 3TC and Kaletra for the baby. Assessment I am worried because these drugs are not licensed for use in the newborn and the doses are not given in the BNF C Recommendation

SBAR Situation I am the pharmacist for the maternity unit and I am phoning to discuss the prescription for antiretrovirals for Baby A Background I see the mother is HIV positive and on treatment and that you have prescribed ABC, 3TC and Kaletra for the baby. Assessment I am worried because we usually use Zidovudine, because these drugs are not licensed for use in the newborn and because the doses are not given in the BNF C Recommendation Can you tell me why the baby needs triple therapy? Can you direct me to the guideline you are using for selection of drug and dosage?

‘Swiss Cheese’ INSTITUTIONAL SYSTEMS FAILURE PROCESS & PROCEDURES FAILURE HUMAN FACTORS TEAM WORKING FAILURE HOLES LINE UP… INDIVIDUAL FAILINGS COMBINE TO LEAD TO UNTOWARD EVENT HAZARDS UNTOWARD EVENT

‘Swiss Cheese’ MANUFACTURER FAILS TO MAKE PAEDIATRIC FORMULATION HOSPITAL DECIDES TO DILUTE ADULT FORMULATION TECHNICIAN ASSUMES THEY ARE DEALING WITH USUAL PAEDIATRIC FORMULATION HOLES LINE UP… INDIVIDUAL FAILINGS COMBINE TO LEAD TO UNTOWARD EVENT HAZARDS Baby gets overdose

Gentamicin care bundle

Background to alert development PSA Neonatal Nurses Association

Why do we need an alert? Used in 89 per cent of neonatal units Over 500 patient safety incidents reported to NPSA in 2008/2009 Side effects include vestibular and auditory damage, and nephrotoxicity Narrow therapeutic range necessitates regular monitoring of blood serum concentrations

Factors influencing prescribing and administration Dosing regimens vary across the country There is no consensus on guidelines for dosing with some units using British National Formulary guidance and others using local variations Mechanisms for measuring levels are not agreed and are not a priority in some units – the monitoring needs of neonates are not given parity with other patients. The availability of specialist pharmacist advice in units is very variable

Development of the care bundle Very little published evidence of the use of care bundles in neonates COSMIC study to identify interventions which can be used to reduce errors e.g. electronic prescribing system, double checking, smart pump and Centralised Intravenous Additive Service (CIVAS) can potentially reduce dosing errors

Reporting and Learning data A review of the top five medications involved in neonatal incidents reported to the NPSA RLS was carried out. The stage of the process when the incident took place, the incident type and the degree of harm caused was reviewed

Root causes of incidents Poor prescribing practice Lack of clearly assigned responsibility relating to blood levels Lack of clearly assigned responsibility during the preparation, checking and administration phase Poor communication between medical and nursing staff Interruptions, particularly during the preparation and administration phase

Proposed measures to reduce errors Dose calculator Standardisation of dose and frequency Clinical Pharmacy input Training, education and communication Role clarification Taking of blood levels Specific gentamicin prescription chart

Agreed Care Bundle components

A policy of no interruptions during drug preparation and administration A disposable, coloured apron Aprons conform to local infection control requirements Parents were informed of the significance of this policy by staff All staff had to “sign up” to avoiding interrupting those involved in the preparation, checking and administering of gentamicin

Use 24 hour clock when prescribing During this pilot, staff were taught to avoid using 24h00 or 00h00 when prescribing, as the risk of the dose being administered a day too early or too late was increased. 24 hour clocks were purchased by participating units

Use of a drug checking prompt provided a checklist of key information included a reminder that drug levels should be monitored and the dose adjusted

Dose to be given within 1 hour either side of the prescribed dosing time This intervention prompted awareness of the need to ensure that blood levels were done and acted upon and maximised the opportunity to ensure that therapeutic blood levels were achieved

What does the alert say?

Any Questions?

Summary Understanding the Human Factors which operate to interfere with medicines safety is vital There are systems, processes and procedures which help prevent errors – use them.